TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein

American Journal of Transplantation

Volumn 4, Issue 9, 2004, Pages 1429-1439

  Tesar, Bethany M ^a   Zhang, Jiasheng ^a   Li, Qi ^a   Goldstein, Daniel R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Mice; Transplantation

Indexed keywords

ADAPTOR PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN ALLOGRAFT; TH1 CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; BONE MARROW CELLS; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, IMMUNOLOGIC; SKIN TRANSPLANTATION; TH1 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 4344703413     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00544.x     Document Type: Article

References (38)

1. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5-11.
2. Barton GM, Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 2002; 14: 380-383.
3. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
4. Heil F, Hemmi H, Hochrein H et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8. Science 2004; 303: 1526-1529.
5. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA. Science 2004; 303: 1529-1531.
6. Zhang D, Zhang G, Hayden MS et al. A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria. Science 2004; 303: 1522-1526.
7. Luster AD. The role of chemokines in linking innate and adaptive immunity. [Review]. Curr Opin Immunol 2002; 14: 129-135.
8. Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002; 296: 298-300.
9. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.
10. Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A. In the absence of IL-12, CD4 (+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10 (-/-) setting. Immunity 2002; 16: 429-439.
11. Asea A, Rehli M, Kabingu E et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277: 15028-15034.
12. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233-5239.
13. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164: 558-561.
14. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002; 168: 5989-5992.
15. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 603-607.
16. Pockley AG. Heat shock proteins, anti-heat shock protein reactivity and allograft rejection. Transplantation 2001; 71: 1503-1507.
17. Palmer SM, Burch LH, Davis RD et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003; 168: 628-632.
18. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003; 111: 1571-1578.
19. Goldstein DR, Chang T, Sweeney SD, Kirklin JK, Thomas JM, George JF. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells. Transplantation 2000; 70: 1068-1073.
20. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. the role of H-2D, H-2K and non H-2 antigens. Transplantation 1973; 16: 343-350.
21. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 2001; 166: 5688-5694.
22. Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation 2002; 73: 1373-1381.
23. Saleem S, Konieczny BT, Lowry RP, Baddoura FK, Lakkis FG. Acute rejection of vascularized heart allografts in the absence of IFNγamma. Transplantation 1996; 62: 1908-1911.
24. Zand MS, Li Y, Hancock W et al. Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation 2000; 70: 1378-1381.
25. Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002; 420: 329-333.
26. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003; 4: 161-167.
27. Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301: 640-643.
28. Hoebe KX, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. [comment]. Nature 2003; 424: 743-748.
29. Yamamoto M, Sato S, Hemmi H et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002; 420: 324-329.
30. Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 413: 78-83.
31. Hoebe K, Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat Immunol 2003; 4: 1223-1229.
32. Samstein B, Johnson GB, JL. P. Toll-like receptor-4 and allograft responses. Transplantation 2004; 15: 475-477.
33. Peiser L, De Winther MP, Makepeace K et al. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun 2002; 70: 5346-5354.
34. Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. [Review]. Curr Opin Immunol 2002; 14: 123-128.
35. Underhill DM. Toll-like receptors: networking for success. Eur J Immunol 2003; 33: 1767-1775.
36. Konieczny BT, Dai Z, Elwood ET et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059-2064.
37. Dai Z, Konieczny BT, Lakkis FG. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. J Immunol 2000; 165: 3031-3036.
38. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-1036.